Deutsche Bank’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Deutsche Bank’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-559	Closed	-$2K	–	5637
2015 Q4	$2K	Hold	559	–	–	﹤0.01%	5174
2015 Q3	$3K	Sell	559 -957	-63%	-$11.7K	﹤0.01%	5103
2015 Q2	$23K	Buy	1,516 +690	+84%	+$8.38K	﹤0.01%	4881
2015 Q1	$8K	Sell	826 -3,877	-82%	-$39.6K	﹤0.01%	4842
2014 Q4	$49K	Buy	4,703 +4,203	+841%	+$41.1K	﹤0.01%	5141
2014 Q3	$4K	Buy	+500	New	+$5.11K	﹤0.01%	5597

Deutsche Bank's RPTP Position: Q4 2016 in Review

Deutsche Bank sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 1,214,418 shares — an estimated $10.9M sold.

Deutsche Bank first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $10.9M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Deutsche Bank reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Deutsche Bank sold 1,214,418 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $10.9M.
Deutsche Bank first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
Deutsche Bank's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $10.9M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.